YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Cipla
Cipla
BSE: 500087NSE: CIPLAISIN: INE059A01026

21st-Oct-2020 12:39Source: BSE

Cipla - Statement Of Investor Complaints For The Quarter Ended September 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0440
Name of the Signatory :- Rajendra Chopra
Designation :- Company Secretary and Compliance Officer

Sections